We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:MYGN

Myriad Genetics (MYGN)

Nasdaq • MYGN • US62855J1043

5.92Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 10.5% of free float sold short, 2.7 days to cover, cost to borrow 1.02%. Sign up for live short interest data.

Market Cap

567m USD | # 5795 in US

Volume

2.31m shares | 9.74m USD

Shares Outstanding

95.7m

Free Float Shares

82.90% | 79.34m

DB:MYD|

XTRA:MYD|

LSE:0K3W

News

MYGN key data

Myriad Genetics (Nasdaq: MYGN) has a market capitalization of $566.54M. Last close $5.92 (as of 2026-11-09); 52-week range $2.74 to $8.09. ORTEX data as of 2026-10-22: short interest was 10.54% of free float, 2.7 days to cover and the average cost to borrow was 1.02%. Sign up for live short interest data.

MYGN news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.